Cargando…
Dose finding in drug development
Autor principal: | Ting, Naitee |
---|---|
Lenguaje: | eng |
Publicado: |
Springer
2006
|
Materias: | |
Acceso en línea: | https://dx.doi.org/10.1007/0-387-33706-7 http://cds.cern.ch/record/1638125 |
Ejemplares similares
-
Phase II clinical development of new drugs
por: Ting, Naitee, et al.
Publicado: (2017) -
Design and analysis of subgroups with biopharmaceutical applications
por: Ting, Naitee, et al.
Publicado: (2020) -
22nd annual Applied Statistics Symposium of the International Chinese Statistical Association (ICSA), jointly with the International Society for Biopharmaceutical Statistics (ISBS)
por: Chen, Zhen, et al.
Publicado: (2015) -
Modern dose-finding designs for cancer phase I trials: drug combinations and molecularly targeted agents
por: Hirakawa, Akihiro, et al.
Publicado: (2018) -
Modeling Dose-Response Microarray Data in Early Drug Development Experiments Using R: Order-Restricted Analysis of Microarray Data
por: Lin, Dan, et al.
Publicado: (2012)